title: Statin-induced proinflammatory response in mitogen-activated peripheral blood mononuclear cells through the activation of caspase-1 and IL-18 secretion in monocytes.
abstract: Statins, which inhibit 3-hydroxy-3-methylglutaryl CoA reductase, have been shown recently to promote proinflammatory responses. We show in this study that both atorvastatin and simvastatin induced proinflammatory responses in mitogen-activated PBMCs by increasing the number of T cells secreting IFN-gamma. This is abolished by the presence of mevalonate, suggesting that statins act specifically by blocking the mevalonate pathway for cholesterol synthesis to promote the proinflammatory response. Both statins at low concentrations induced a dose-dependent increase in the number of IFN-gamma-secreting T cells in mitogen-activated PBMCs, whereas at higher concentrations the effect was abolished. The proinflammatory effect of statins was not seen in purified T cells per se activated with mitogen. However, conditioned medium derived from statin-treated PBMCs enhanced the number of IFN-gamma-secreting cells in activated purified T cells. This effect was not blocked by mevalonate, but was abolished by neutralizing Abs to IL-18 and IL-12. Similarly, the up-regulation of IFN-gamma-secreting T cells in PBMCs costimulated with statins and mitogens was blocked by the neutralizing anti-IL-18 and anti-IL-12. We showed that simvastatin stimulates the secretion of IL-18 and IL-1beta in monocytes. Active caspase-1, which is required for the processing and secretion of IL-18 and IL-1beta, was activated in simvastatin-treated monocytes. This was blocked by mevalonate and the caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone. Taken together, the proinflammatory response mediated by statins in activated PBMCs is mediated mainly via the activation of caspase-1 and IL-18 secretion in the monocytes and to a lesser extent by IL-12.
authors.affiliation: Medical Research Council Toxicology Unit, University of Leicester, Lancaster Road, Leicester, United Kingdom.
authors.forename: William R
authors.initials: WR
authors.lastname: Coward
authors.forename: Ayman
authors.initials: A
authors.lastname: Marei
authors.forename: AiLi
authors.initials: A
authors.lastname: Yang
authors.forename: Mariuca M
authors.initials: MM
authors.lastname: Vasa-Nicotera
authors.forename: Sek C
authors.initials: SC
authors.lastname: Chow
mesh_terms: D000590:Amino Acid Chloromethyl Ketones / Q000494:pharmacology; D000906:Antibodies / Q000276:immunology; D000069059:Atorvastatin; D018106:CD28 Antigens / Q000276:immunology; D017252:CD3 Complex / Q000276:immunology; D020170:Caspase 1 / Q000378:metabolism*; D002478:Cells, Cultured; D004789:Enzyme Activation / Q000187:drug effects; D006538:Heptanoic Acids / Q000494:pharmacology*; D006801:Humans; D007249:Inflammation / Q000139:chemically induced / Q000276:immunology / Q000378:metabolism; D007371:Interferon-gamma / Q000378:metabolism; D007375:Interleukin-1 / Q000378:metabolism; D018664:Interleukin-12 / Q000378:metabolism; D020382:Interleukin-18 / Q000378:metabolism*; D008798:Mevalonic Acid / Q000494:pharmacology; D008938:Mitosis / Q000187:drug effects; D009000:Monocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism*; D011758:Pyrroles / Q000494:pharmacology*; D019821:Simvastatin / Q000494:pharmacology*; D012995:Solubility; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism
chemical_list: D000590:Amino Acid Chloromethyl Ketones; D000906:Antibodies; D018106:CD28 Antigens; D017252:CD3 Complex; D006538:Heptanoic Acids; D007375:Interleukin-1; D020382:Interleukin-18; D011758:Pyrroles; C096713:benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone; D018664:Interleukin-12; D007371:Interferon-gamma; D000069059:Atorvastatin; D019821:Simvastatin; D020170:Caspase 1; D008798:Mevalonic Acid